ReviewMicroorganisms2026
Review of Infections in Immunocompromised Travellers: Epidemiology, Infection Prevention and Management.
Review in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
International travel has increased significantly in recent years. Many travellers are immunocompromised, making them more susceptible to infectious diseases due to their weakened immune systems. This narrative review provides an overview of infection epidemiology, prevention strategies, and clinical management for immunocompromised travellers. We demonstrate the role of pre-travel consultation, emphasizing individualized risk assessment informed by destination-specific epidemiology, immune status, and underlying conditions. Key preventive interventions, including vaccination strategies, antimicrobial prophylaxis, and detailed health counseling, in addition to practical measures that can be taken to minimize infection risk during travel, are addressed. Post-travel surveillance and early recognition of travel-related infections are analyzed, highlighting the importance of prompt symptom evaluation. Effective care for immunocompromised travellers requires a multidisciplinary framework that integrates patients, primary care physicians, infectious disease specialists, and travel medicine experts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.